The Ncf1 gene, encoding the P47PHOX protein that regulates production of reactive oxygen species (ROS) by the phagocyte NADPH oxidase (NOX2) complex, is associated with autoimmunity and arthritis severity in rats. We have now identified that the single-nucleotide polymorphism (SNP) resulting in an M153T amino acid substitution mediates arthritis resistance and thus explains the molecular polymorphism underlying the earlier identified Ncf1 gene effect. We identified the SNP in position 153 to regulate ROS production using COSPHOX cells transfected with mutated Ncf1. To determine the role of this SNP for control of arthritis, we used the Wistar strain, identified to carry only the postulated arthritis resistant SNP in position 153. When this Ncf1 allele was backcrossed to the arthritis susceptible DA strain, both granulocyte ROS production and arthritis resistance were restored. Position 153 is located in the hinge region between the PX and SH3 domains of P47PHOX. Mutational analysis of this position revealed a need for an −OH group in the side chain but we found no evidence for phosphorylation. The polymorphism did not affect assembly of the P47PHOX/P67PHOX complex in the cytosol or membrane localization, but is likely to operate downstream of assembly, affecting activity of the membrane NOX2 complex. Antioxid. Redox Signal. 14, 2373–2383.
Get full access to this article
View all access options for this article.
References
1.
AgoT, NunoiH, ItoT, SumimotoH. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem, 274:33644–33653. 1999.
2.
AgoT, TakeyaR, HiroakiH, KuribayashiF, ItoT, KohdaD, SumimotoH. The PX domain as a novel phosphoinositide-binding module. Biochem Biophys Res Commun, 287:733–738. 2001.
3.
AhlqvistE, HultqvistM, HolmdahlR. The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther, 11:226. 2009.
4.
AitmanTJ, CritserJK, CuppenE, DominiczakA, Fernandez-SuarezXM, FlintJ, GauguierD, GeurtsAM, GouldM, HarrisPC, HolmdahlR, HubnerN, IzsvakZ, JacobHJ, KuramotoT, KwitekAE, MarroneA, MashimoT, MorenoC, MullinsJ, MullinsL, OlssonT, PravenecM, RileyL, SaarK, SerikawaT, ShullJD, SzpirerC, TwiggerSN, VoigtB, WorleyK. Progress and prospects in rat genetics: a community view. Nat Genet, 40:516–522. 2008.
5.
AntonellA, de LuisO, Domingo-RouraX, Perez-JuradoLA. Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23. Genome Res, 15:1179–1188. 2005.
6.
BabiorBM. NADPH oxidase: an update. Blood, 93:1464–1476. 1999.
BauerK, YuX, WernhoffP, KoczanD, ThiesenHJ, IbrahimSM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum, 50:3721–3728. 2004.
9.
BayesM, MaganoLF, RiveraN, FloresR, Perez JuradoLA. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet, 73:131–151. 2003.
10.
BecanovicK, JagodicM, ShengJR, DahlmanI, Aboul-EneinF, WallstromE, OlofssonP, HolmdahlR, LassmannH, OlssonT. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol, 176:6055–6064. 2006.
11.
BedardK, KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
12.
BergsteinsdottirK, YangHT, PetterssonU, HolmdahlR. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol, 164:1564–1568. 2000.
13.
BrunsbergU, GustafssonK, JanssonL, MichaelssonE, Ahrlund-RichterL, PetterssonS, MattssonR, HolmdahlR. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol, 24:1698–1702. 1994.
14.
BrunsonT, WangQ, ChambersI, SongQ. A copy number variation in human NCF1 and its pseudogenes. BMC Genet, 11:13. 2010.
15.
BurrittJB, QuinnMT, JutilaMA, BondCW, JesaitisAJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem, 270:16974–16980. 1995.
16.
ChanockSJ, el BennaJ, SmithRM, BabiorBM. The respiratory burst oxidase. J Biol Chem, 269:24519–24522. 1994.
17.
DahlgrenC, KarlssonA. Respiratory burst in human neutrophils. J Immunol Methods, 232:3–14. 1999.
18.
de MendezI, HomayounpourN, LetoTL. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol Cell Biol, 17:2177–2185. 1997.
19.
Del CampoM, AntonellA, MaganoLF, MunozFJ, FloresR, BayesM, Perez JuradoLA. Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet, 78:533–542. 2006.
20.
DusiS, Della BiancaV, GrzeskowiakM, RossiF. Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2+)-depleted human neutrophils. Biochem J, 290,Pt 1:173–178. 1993.
21.
El-BennaJ, DangPM, Gougerot-PocidaloMA, MarieJC, Braut-BoucherF. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med, 41:217–225. 2009.
22.
FreemanJL, LambethJD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem, 271:22578–22582. 1996.
23.
GatevaV, SandlingJK, HomG, TaylorKE, ChungSA, SunX, OrtmannW, KosoyR, FerreiraRC, NordmarkG, GunnarssonI, SvenungssonE, PadyukovL, SturfeltG, JonsenA, BengtssonAA, Rantapaa-DahlqvistS, BaechlerEC, BrownEE, AlarconGS, EdbergJC, Ramsey-GoldmanR, McGwinGJr., ReveilleJD, VilaLM, KimberlyRP, ManziS, PetriMA, LeeA, GregersenPK, SeldinMF, RonnblomL, CriswellLA, SyvanenAC, BehrensTW, GrahamRR. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet, 41:1228–1233. 2009.
24.
GeldermanKA, HultqvistM, HolmbergJ, OlofssonP, HolmdahlR. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci USA, 103:12831–12836. 2006.
25.
GeldermanKA, HultqvistM, PizzollaA, ZhaoM, NandakumarKS, MattssonR, HolmdahlR. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest, 117:3020–3028. 2007.
GregersenPK, OlssonLM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol, 27:363–391. 2009.
28.
GroempingY, LapougeK, SmerdonSJ, RittingerK. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell, 113:343–355. 2003.
29.
GroempingY, RittingerK. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J, 386:401–416. 2005.
30.
HellmanU. Peptide mapping using MALDI-TOFMS. Mass Spectrometry and Hyphenated Techniques in Neuropeptide Research. Silberring JaER. New York, NY: John Wiley & Sons, Inc., 2002; 259–275.
31.
HeyworthPG, CurnutteJT, NauseefWM, VolppBD, PearsonDW, RosenH, ClarkRA. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest, 87:352–356. 1991.
32.
HeyworthPG, NoackD, CrossAR. Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection. Blood, 100:1845–1851. 2002.
HolmdahlR, JanssonL, AnderssonM, LarssonE. Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology, 65:305–310. 1988.
35.
HultqvistM, OlofssonP, GeldermanKA, HolmbergJ, HolmdahlR. A new arthritis therapy with oxidative burst inducers. PLoS Med, 3:e348. 2006.
36.
HultqvistM, OlofssonP, HolmbergJ, BackstromBT, TordssonJ, HolmdahlR. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA, 101:12646–12651. 2004.
37.
HultqvistM, OlssonLM, GeldermanKA, HolmdahlR. The protective role of ROS in autoimmune disease. Trends Immunol, 30:201–208. 2009.
38.
IshiharaH, MartinBL, BrautiganDL, KarakiH, OzakiH, KatoY, FusetaniN, WatabeS, HashimotoK, UemuraDet al.Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun, 159:871–877. 1989.
39.
KarathanassisD, StahelinRV, BravoJ, PerisicO, PacoldCM, ChoW, WilliamsRL. Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J, 21:5057–5068. 2002.
40.
KoshkinV, LotanO, PickE. The cytosolic component p47(phox) is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production. J Biol Chem, 271:30326–30329. 1996.
41.
LambethJD, KrauseKH, ClarkRA. NOX enzymes as novel targets for drug development. Semin Immunopathol, 30:339–363. 2008.
42.
LetoTL, AdamsAG, de MendezI. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci USA, 91:10650–10654. 1994.
43.
LeusenJH, BolscherBG, HilariusPM, WeeningRS, KaulferschW, SegerRA, RoosD, VerhoevenAJ. 156Pro—>Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med, 180:2329–2334. 1994.
44.
LindqvistAK, JohannessonM, JohanssonAC, NandakumarKS, BlomAM, HolmdahlR. Backcross and partial advanced intercross analysis of nonobese diabetic gene-mediated effects on collagen-induced arthritis reveals an interactive effect by two major loci. J Immunol, 177:3952–3959. 2006.
45.
LundqvistH, DahlgrenC. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med, 20:785–792. 1996.
46.
NobuhisaI, TakeyaR, OguraK, UenoN, KohdaD, InagakiF, SumimotoH. Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox. Biochem J, 396:183–192. 2006.
47.
OguraK, NobuhisaI, YuzawaS, TakeyaR, TorikaiS, SaikawaK, SumimotoH, InagakiF. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide. J Biol Chem, 281:3660–3668. 2006.
48.
OlofssonP, HolmbergJ, PetterssonU, HolmdahlR. Identification and isolation of dominant susceptibility loci for pristane-induced arthritis. J Immunol, 171:407–416. 2003.
49.
OlofssonP, HolmbergJ, TordssonJ, LuS, AkerstromB, HolmdahlR. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet, 33:25–32. 2003.
50.
OlofssonP, HolmdahlR. Positional cloning of Ncf1—a piece in the puzzle of arthritis genetics. Scand J Immunol, 58:155–164. 2003.
51.
OlssonLM, LindqvistAK, KallbergH, PadyukovL, BurkhardtH, AlfredssonL, KlareskogL, HolmdahlR. A case-control study of Rheumatoid arthritis identifies an associated SNP in the NCF4 gene supporting a role for the NOX-complex in autoimmunity. Arthritis Res Ther, 9:R98. 2007.
52.
PriceMO, McPhailLC, LambethJD, HanCH, KnausUG, DinauerMC. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood, 99:2653–2661. 2002.
53.
RiouxJD, XavierRJ, TaylorKD, SilverbergMS, GoyetteP, HuettA, GreenT, KuballaP, BarmadaMM, DattaLW, ShugartYY, GriffithsAM, TarganSR, IppolitiAF, BernardEJ, MeiL, NicolaeDL, RegueiroM, SchummLP, SteinhartAH, RotterJI, DuerrRH, ChoJH, DalyMJ, BrantSR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet, 39:596–604. 2007.
54.
RoepstorffK, RasmussenI, SawadaM, Cudre-MarouxC, SalmonP, BokochG, van DeursB, VilhardtF. Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis. J Biol Chem, 283:7983–7993. 2008.
55.
RotheG, OserA, ValetG. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften, 75:354–355. 1988.
56.
ShenK, SergeantS, HantganRR, McPhailLC, HoritaDA. Mutations in the PX-SH3A linker of p47phox decouple PI(3,4)P2 binding from NADPH oxidase activation. Biochemistry, 47:8855–8865. 2008.
57.
ShioseA, SumimotoH. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J Biol Chem, 275:13793–13801. 2000.
58.
SumimotoH, HataK, MizukiK, ItoT, KageY, SakakiY, FukumakiY, NakamuraM, TakeshigeK. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem, 271:22152–22158. 1996.
59.
SumimotoH, KageY, NunoiH, SasakiH, NoseT, FukumakiY, OhnoM, MinakamiS, TakeshigeK. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA, 91:5345–5349. 1994.
60.
TauraM, MiyanoK, MinakamiR, KamakuraS, TakeyaR, SumimotoH. A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase. Biochem J, 419:329–338. 2009.
61.
van BruggenR, AnthonyE, Fernandez-BorjaM, RoosD. Continuous translocation of Rac2 and the NADPH oxidase component p67(phox) during phagocytosis. J Biol Chem, 279:9097–9102. 2004.
62.
van der Helm-van MilAH, PadyukovL, ToesRE, KlareskogL, HuizingaTW. Genome-wide single-nucleotide polymorphism studies in rheumatology: Hype or hope?Arthritis Rheum, 58:2591–2597. 2008.
63.
Vingsbo-LundbergC, NordquistN, OlofssonP, SundvallM, SaxneT, PetterssonU, HolmdahlR. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet, 20:401–404. 1998.
64.
VowellsSJ, SekhsariaS, MalechHL, ShalitM, FleisherTA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods, 178:89–97. 1995.
65.
VutskitsGV, SalmonP, MayorL, VutskitsL, Cudre-MaurouxC, SorianoJ, MontesanoR, MailletP, SappinoAP. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells. Breast Cancer Res Treat, 99:143–153. 2006.
66.
WooleyPH, LuthraHS, StuartJM, DavidCS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med, 154:688–700. 1981.
67.
YoungMA, GonfloniS, Superti-FurgaG, RouxB, KuriyanJ. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell, 105:115–126. 2001.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
